Viewing StudyNCT05911958



Ignite Creation Date: 2024-05-06 @ 7:09 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05911958
Status: RECRUITING
Last Update Posted: 2023-12-20
First Post: 2023-06-12

Brief Title: A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive Low HER2 Expression Breast Cancer
Sponsor: Henan Cancer Hospital
Organization: Henan Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
HER2 Low Breast Carcinoma
Keywords: